Oncology Target Services
-
Manufactured by Sengenicsbased in USA
Rapidly screen promising immuno-oncology targets; Sengenics helps accelerate oncology drug discovery with fast and efficient screening of immunotherapy drug ...
-
Manufactured by SOFIEbased in USA
Staying true to our vision to improve patient outcomes by developing and delivering molecular diagnostics and therapeutics, SOFIE has acquired global rights for the diagnostic and companion diagnostic use of the FAPI family of compounds from University of Heidelberg, the team that invented PSMA-617 (Novartis). The FAPI family of compounds have demonstrated promising theranostic ...
-
Manufactured by OSE Immunotherapeuticsbased in FRANCE
Complementary Research & Development areas of expertise in immunology. Accelerating target identification, product validation and beyond. Delivering first-in-class therapies activating and regulating the immune ...
-
by OracleBiobased in UNITED KINGDOM
At OracleBio, we have extensive experience in providing pre-clinical services to support clients in the early stages of the drug discovery pipeline. We understand that our clients need their data quickly, so we work hard to ensure a fast turnaround time, with a team of dedicated image analysis scientists and high-powered computing servers for fast image processing. ...
-
based in UNITED KINGDOM
Viewing cancer through the immune lens (immuno-oncology) has led to the most promising advancements in cancer treatment in recent history, nonetheless the full potential of the approach is as yet ...
-
by Sectra ABbased in SWEDEN
Sectra’s enterprise imaging portfolio gives you a unified strategy for all your imaging needs, and lets you improve patient outcome while lowering operational costs. With our solutions, you can reduce the number of systems while providing top-of-the-line diagnostic capabilities spanning both image-intense departments such as radiology, breast imaging, pathology, orthopaedics, and cardiology ...
-
by Oncodesignbased in FRANCE
EXPLORE, a new service to identify and validate therapeutic targets, primarily cancer treatments – an area of expertise and excellence at Oncodesign to discover and investigate preclinical proofs of concept involving a wide variety of different approaches and anti-cancer mechanisms of action. EXPLORE, is the combination of our ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you